PRFX
PRF Technologies Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$0.71
−8.88%Latest reported
- Last report date
- Oct 2, 2025
- EPS actual
- -$9.60
- EPS estimate
- —
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -2106.7%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 2, 2025 | — | -$9.60 | — | — |
| Jun 4, 2025 | — | -$14 | — | — |
| Nov 19, 2024 | -$4.74 | -$15 | Miss -217.23% | — |
| Aug 15, 2024 | -$6.24 | -$9.60 | Miss -53.85% | — |
| May 15, 2024 | -$2.40 | -$65 | Miss -2619.58% | $0.00 |
| Feb 29, 2024 | -$1.49 | -$84 | Miss -5536.24% | — |
| Nov 15, 2023 | -$1.40 | $12 | Beat 922.86% | — |
| Aug 10, 2023 | -$300 | -$1.2K | Miss -306.83% | — |
| May 15, 2023 | -$264 | -$53 | Beat 80.00% | — |
| Mar 16, 2023 | -$180 | -$70 | Beat 61.34% | $86.0K |
| Nov 15, 2022 | -$41 | -$48 | Miss -17.62% | — |
| Aug 15, 2022 | -$0.16 | -$41 | Miss -25393.75% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Jul 2, 2026